In addition, the presence of the K108N-SEMA3A mutation also does not alter ALS-induced muscle wasting or confer a survival benefit on ALS mice harboring the mutation (S1 Fig). This evidence concerns the gene SEMA3A and amyotrophic lateral sclerosis.